Table 1. Clinical characteristics and laboratory data.
| Patient ID | Sex | Age (years) | ESRD (age) | Hearing loss (detected age) | sCr (mol/l) | eGFR (ml/min/1.73 m2) | Hematuria | U-P/Cr (g/g Cr) | EM | alpha-5 | Family history |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 | M | 15–20 | — | — | 68.9 | 144.7 | 3+ | 0.74 | BWC | Mosaic | Sporadic |
| 28 | M | 35–40 | — | — | 68.9 | 87.1 | — | — | — | — | Two daughters pro/OB |
| 52 | M | 15–20 | — | — | 80.4 | 125 | 3+ | 0.83 | BWC | Mosaic | Sporadic |
| 252 | M | 40–45 | — | — | 86.6 | 104.1 | 3+ | — | — | — | Daughter pro/OB |
Abbreviations: BWC, basket-weave change; EASRD, end-stage renal disease; eGFR, estimated glomerular filtration rate; EM, electron microscopic findings; M, male; ND, not determined; OB, occult; pro, proteinuria; blood sCr, serum creatinine levels; U-P/Cr, urinary protein–creatinine ratio.